CD274 and melanoma: Noteworthy, a recent study also revealed that recurrent melanoma after ACT treatment exhibited high expression of IFN-γ signaling (PD-1, PD-L1, CTLA-4, though the picture was heterogeneous), which provided tractable targets for salvage immunotherapy, and indeed allowed for effective ICB [150].